Frontiers in Cardiovascular Medicine | Lipids in Cardiovascular Disease

Correction

Accepted on 06 Aug 2025

Corrigendum:Association between extremely high-density lipoprotein cholesterol and adverse cardiovascular outcomes: a systematic review and meta-analysis

in Lipids in Cardiovascular Disease

Guanwei Zhang
Jiajuan Guo
Hongguang Jin
Xiaojing Wei
Xing Zhu
Weitao Jia
Yongsheng Huang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1679996

104 views

Original Research

Accepted on 06 Aug 2025

Remnant cholesterol, not LDL cholesterol, is associated with the risk of hypertension in the middle-aged and elderly population: Bushehr Elderly Health (BEH) cohort

in Lipids in Cardiovascular Disease

Behnaz Esmaeili
Shahnaz Esmaeili
Noushin Fahimfar
Mostafa Rezaei Tavirani
Farideh Razi
Iraj Nabipour
Patricia Khashayar
Fatemeh Bandarian

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1483778

170 views

Original Research

Accepted on 04 Aug 2025

Patterns and characteristics of dyslipidemia subtypes among community-dwelling elderly in Eastern China: A Cross-Sectional Study

in Lipids in Cardiovascular Disease

Xiaomeng Mi
Suting Xiong
Wenguo Xu
Fang Yao
Jie Huang
Lan Cui
Yu Qin
Jian Su
Wenchao Xu
Ran Tao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1634134

140 views

Original Research

Published on 14 Jul 2025

Association between fasting glucose/high-density lipoprotein cholesterol ratio and cardiovascular disease risk in Chinese middle-aged and older adults: a longitudinal study

in Lipids in Cardiovascular Disease

Jintao Chen
Liying Yan
Jianhai Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1609891

1,211 views

Mini Review

Published on 10 Jul 2025

Reverse cholesterol transport: current assay methods, alterations with disease and response to therapeutic intervention

in Lipids in Cardiovascular Disease

Martin P. Playford
Edward B. Neufeld
Rafael Zubirán
Alan T. Remaley

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1608384

1,267 views

Original Research

Published on 08 Jul 2025

Lipoprotein(a) as an early marker of cardiovascular events in high-risk subjects: insights from the Moli-sani cohort study

in Lipids in Cardiovascular Disease

Francesco Gianfagna
Simone Poli
Simona Costanzo
Augusto Di Castelnuovo
Teresa Panzera
Amalia De Curtis
Sara Magnacca
Mariarosaria Persichillo
Lorenzo De Santi
Claudia Cristofani

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1571395

1,596 views

Opinion

Published on 01 Jul 2025

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?

in Lipids in Cardiovascular Disease

Alpo Vuorio
Frederick J. Raal
Petri T. Kovanen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1624049

1,704 views

Original Research

Published on 30 Jun 2025

Non-high-density lipoprotein cholesterol predicts cardiovascular risk better than remnant cholesterol in patients with type 2 diabetes mellitus

in Lipids in Cardiovascular Disease

Paul Nsiah
Samuel Acquah
Ansumana Sandy Bockarie
George Adjei
Ebenezer Aniakwaa-Bonsu
Oksana Ryabinina

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1551203

1,589 views

Original Research

Published on 19 Jun 2025

Relationship between dynamic changes in remnant cholesterol and cardiovascular disease in middle-aged and older Chinese: a national cohort study

in Lipids in Cardiovascular Disease

Bin Zhang
Dengfeng Ma
Zhiqiang Pei
Qian Ren
Jin Qiu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1503705

1,765 views

Systematic Review

Published on 11 Jun 2025

Global scientific trends in hypercholesterolemia research from 2003 to 2023: a data-driven bibliometric and visual analysis

in Lipids in Cardiovascular Disease

Haoxin Guo
Qihui Wang
Yinling Wang
Xiaolong Dong
Zhongqing Wang
Hui Kang
Shitong Cheng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1524697

1,799 views

Original Research

Published on 09 Jun 2025

Lipid accumulation product index is inversely U-shaped associated with abdominal aortic calcification based on NHANES 2013–2014

in Lipids in Cardiovascular Disease

Jiangbei Deng
Xiao Qin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1524847

1,402 views

Case Report

Published on 09 Jun 2025

Familial hypercholesterolaemia with early-onset coronary artery disease and recurrent in-stent restenosis associated with the LDLR gene c.428G>A mutation: a case report

in Lipids in Cardiovascular Disease

Chengpeng Zhang
Hui Li
Wei Zhang
Jian Huang
Jing Zhu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1573543

1,731 views

Editorial

Published on 29 May 2025

Editorial: Cardiovascular risk and lipoprotein(a): beyond LDL cholesterol

in Lipids in Cardiovascular Disease

Giuseppe Mandraffino
Laura D'Erasmo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1607395

1,141 views

Case Report

Published on 27 May 2025

Case Report: Practical approach to unmask unspecific adverse effects under lipid-lowering medication

in Lipids in Cardiovascular Disease

Thomas Büttner
Gunther Hartmann
Martin Coenen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1604129

1,384 views

Original Research

Published on 22 May 2025

Missing in action: the genetic mysteries of extremely low HDL cholesterol

in Lipids in Cardiovascular Disease

Shoshi Sphitzen
Mordechai Golomb
Mohammad Mowaswes
Refael Bitzur
Smadar Horowitz Cederboim
Ronen R. Leker
Marc Gotkine
Itai Chovers
Daniel Schurr
Eran Leitersdorf

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1553259

1,489 views

Original Research

Published on 13 May 2025

CTRP3 attenuates myocardial lipotoxicity via suppression of lipid accumulation, inflammation, apoptosis, and mitochondrial oxidative stress

in Lipids in Cardiovascular Disease

Qingpeng Wang
Jiangyang Chi
Chen Wang
Yanhong Yuan
Rui Tian
Yun Yang
Xinzhong Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1575929

1,261 views